These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23826527)

  • 1. Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy.
    Tan CS; Chew MC; Lim KH; Lim TH
    Int J Ophthalmol; 2013; 6(3):327-30. PubMed ID: 23826527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM; Lai TY; Wong AL; Liu DT; Lam DS
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hara W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2008 Mar; 145(3):518-526. PubMed ID: 18207125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.
    Tan CS; Chew MC; Lim TH
    Eye (Lond); 2014 Jan; 28(1):17-22. PubMed ID: 24051405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
    Zhu Y; Zhang T; Xu G; Peng L
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization.
    Ikuno Y; Nagai Y; Matsuda S; Arisawa A; Sho K; Oshita T; Takahashi K; Uchihori Y; Gomi F
    Am J Ophthalmol; 2010 Jan; 149(1):140-6. PubMed ID: 19846061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.
    Ruiz-Moreno JM; Montero JA
    Br J Ophthalmol; 2003 Jul; 87(7):856-9. PubMed ID: 12812885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population.
    El Matri L; Kort F; Chebil A; Bouraoui R; Merdassi A; Bouladi M
    Graefes Arch Clin Exp Ophthalmol; 2011 Sep; 249(9):1287-93. PubMed ID: 21484465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.